| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |